{"Company Name": "Avnos, Inc.", "Website": "avnos.com", "Linkedin": "https://www.linkedin.com/company/avnos-inc/", "crunchbase_id": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "data": {"properties": {"facet_ids": ["ai_insight", "builtwith", "company", "contact", "ipqwery", "rank", "siftery"], "title": "Amarillo Biosciences", "short_description": "Amarillo Biosciences is a specialty biopharmaceutical company developing a patented formulation of interferon-alpha.", "identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "cards": {"semrush_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "company_about_fields1": {}, "current_advisors_image_list": [], "recommended_search": [{"org_num": 1319, "queries": {"person": [{"field_id": "rank_person", "operator_id": "lte", "values": [320000], "type": "predicate"}, {"collection_id": "organization.has_primary_organization.forward", "query": [{"field_id": "facet_ids", "operator_id": "includes", "values": ["company"], "type": "predicate"}, {"field_id": "categories", "operator_id": "includes", "values": ["58842728-7ab9-5bd1-bb67-e8e55f6520a0"], "type": "predicate"}, {"field_id": "revenue_range", "operator_id": "includes", "values": ["r_00000000", "r_00001000", "r_00010000"], "type": "predicate"}, {"field_id": "funding_stage", "operator_id": "eq", "values": ["ipo"], "type": "predicate"}, {"field_id": "operating_status", "operator_id": "eq", "values": ["active"], "type": "predicate"}], "type": "sub_query"}], "organization": [{"field_id": "facet_ids", "operator_id": "includes", "values": ["company"], "type": "predicate"}, {"field_id": "categories", "operator_id": "includes", "values": ["58842728-7ab9-5bd1-bb67-e8e55f6520a0"], "type": "predicate"}, {"field_id": "revenue_range", "operator_id": "includes", "values": ["r_00000000", "r_00001000", "r_00010000"], "type": "predicate"}, {"field_id": "funding_stage", "operator_id": "eq", "values": ["ipo"], "type": "predicate"}, {"field_id": "operating_status", "operator_id": "eq", "values": ["active"], "type": "predicate"}], "event": [{"field_id": "categories", "operator_id": "includes", "values": ["58842728-7ab9-5bd1-bb67-e8e55f6520a0"], "type": "predicate"}, {"collection_id": "principal.has_event.forward", "query": [{"field_id": "facet_ids", "operator_id": "includes", "values": ["company"], "type": "predicate"}, {"field_id": "revenue_range", "operator_id": "includes", "values": ["r_00000000", "r_00001000", "r_00010000"], "type": "predicate"}, {"field_id": "funding_stage", "operator_id": "eq", "values": ["ipo"], "type": "predicate"}, {"field_id": "operating_status", "operator_id": "eq", "values": ["active"], "type": "predicate"}], "type": "sub_query"}]}, "identifier": {"permalink": "biotechnology-public-companies-less-than-50m-in-revenue", "image_id": "aadad72rn7qoohb1sf7f", "uuid": "7587a395-d351-48c1-98e9-1fb91b5619c1", "entity_def_id": "hub", "value": "Biotechnology Public Companies With Less Than $50M in Revenue"}, "org_identifiers": [{"permalink": "recursion-pharmaceuticals", "image_id": "aadad72rn7qoohb1sf7f", "uuid": "0bc57a74-cd37-e643-9d5c-2b409f4a7e48", "entity_def_id": "organization", "value": "Recursion Pharmaceuticals"}, {"permalink": "mediwound", "image_id": "yqniacc4gvq9ihy8byji", "uuid": "5081d7cf-84e0-9a6a-cf0f-12b0a300863c", "entity_def_id": "organization", "value": "MediWound"}, {"permalink": "longeveron", "image_id": "b7btjazs0ijnppnl3buq", "uuid": "4723d26a-9bbf-49c5-9ec6-b7e620723c02", "entity_def_id": "organization", "value": "Longeveron"}, {"permalink": "zealand-pharma", "image_id": "v1484029292/ewvtyzgetsu2v4gejb4i.jpg", "uuid": "587f3d14-d3f3-93b0-8dc4-e53321f8c154", "entity_def_id": "organization", "value": "Zealand Pharma"}, {"permalink": "ngm-biopharmaceuticals", "image_id": "v1397181898/244efd963b11666d7478f874ef1ccd57.jpg", "uuid": "5dfc069c-4a9e-6ea6-39de-877ac2e25183", "entity_def_id": "organization", "value": "NGM Biopharmaceuticals"}, {"permalink": "exscientia", "image_id": "llqo7c8i5lqgcug6iged", "uuid": "ae7c6ece-affc-33af-c6f0-474543c34fc1", "entity_def_id": "organization", "value": "Exscientia"}, {"permalink": "benevolent-ai", "image_id": "n6dpv5oz1sbykkvydqlb", "uuid": "b0ba271d-e91d-0800-65b9-216f98a7b0c7", "entity_def_id": "organization", "value": "BenevolentAI"}, {"permalink": "telix-pharmaceuticals", "image_id": "indoqvwh7hgzcyxfwjpp", "uuid": "a1034e86-82f8-0ebb-afde-683e7e795cb4", "entity_def_id": "organization", "value": "Telix Pharmaceuticals"}], "org_funding_total": {"value_usd": 170071116848, "currency": "USD", "value": 170071116848}, "org_num_investors": 6600}, {"org_num": 912, "queries": {"person": [{"field_id": "rank_person", "operator_id": "lte", "values": [500000], "type": "predicate"}, {"collection_id": "organization.has_primary_organization.forward", "query": [{"field_id": "facet_ids", "operator_id": "includes", "values": ["company"], "type": "predicate"}, {"field_id": "categories", "operator_id": "includes", "values": ["9126275d-d470-1524-02f4-93d481721a6e"], "type": "predicate"}, {"field_id": "revenue_range", "operator_id": "includes", "values": ["r_00000000", "r_00001000", "r_00010000", "r_00050000", "r_00100000"], "type": "predicate"}, {"field_id": "funding_stage", "operator_id": "eq", "values": ["ipo"], "type": "predicate"}, {"field_id": "operating_status", "operator_id": "eq", "values": ["active"], "type": "predicate"}], "type": "sub_query"}], "organization": [{"field_id": "facet_ids", "operator_id": "includes", "values": ["company"], "type": "predicate"}, {"field_id": "categories", "operator_id": "includes", "values": ["9126275d-d470-1524-02f4-93d481721a6e"], "type": "predicate"}, {"field_id": "revenue_range", "operator_id": "includes", "values": ["r_00000000", "r_00001000", "r_00010000", "r_00050000", "r_00100000"], "type": "predicate"}, {"field_id": "funding_stage", "operator_id": "eq", "values": ["ipo"], "type": "predicate"}, {"field_id": "operating_status", "operator_id": "eq", "values": ["active"], "type": "predicate"}], "event": [{"field_id": "categories", "operator_id": "includes", "values": ["9126275d-d470-1524-02f4-93d481721a6e"], "type": "predicate"}, {"collection_id": "principal.has_event.forward", "query": [{"field_id": "facet_ids", "operator_id": "includes", "values": ["company"], "type": "predicate"}, {"field_id": "revenue_range", "operator_id": "includes", "values": ["r_00000000", "r_00001000", "r_00010000", "r_00050000", "r_00100000"], "type": "predicate"}, {"field_id": "funding_stage", "operator_id": "eq", "values": ["ipo"], "type": "predicate"}, {"field_id": "operating_status", "operator_id": "eq", "values": ["active"], "type": "predicate"}], "type": "sub_query"}]}, "identifier": {"permalink": "medical-public-companies-less-than-500m-in-revenue", "image_id": "m6bcwbhbrtd1b4kbs1h2", "uuid": "728fde94-97ef-46fa-b282-0b329f19d9c5", "entity_def_id": "hub", "value": "Medical Public Companies With Less Than $500M in Revenue"}, "org_identifiers": [{"permalink": "valneva", "image_id": "m6bcwbhbrtd1b4kbs1h2", "uuid": "1ebbeb9a-cfd2-4165-0bdb-6c103c051de5", "entity_def_id": "organization", "value": "Valneva"}, {"permalink": "longeveron", "image_id": "b7btjazs0ijnppnl3buq", "uuid": "4723d26a-9bbf-49c5-9ec6-b7e620723c02", "entity_def_id": "organization", "value": "Longeveron"}, {"permalink": "organigram", "image_id": "viidplvryeblxwxir3mm", "uuid": "0aa97c3c-9113-2726-2a8a-f43f52b11654", "entity_def_id": "organization", "value": "OrganiGram"}, {"permalink": "weave", "image_id": "xofgjos2nwfbahipkshf", "uuid": "bcccd725-9682-dc22-eadf-979ce108d353", "entity_def_id": "organization", "value": "Weave"}, {"permalink": "ngm-biopharmaceuticals", "image_id": "v1397181898/244efd963b11666d7478f874ef1ccd57.jpg", "uuid": "5dfc069c-4a9e-6ea6-39de-877ac2e25183", "entity_def_id": "organization", "value": "NGM Biopharmaceuticals"}, {"permalink": "senti-biosciences", "image_id": "k9g8kud5muvyz6o0evvl", "uuid": "1d32c9a7-6560-403c-9f49-2e91960307fe", "entity_def_id": "organization", "value": "Senti Biosciences"}, {"permalink": "carmat-2", "image_id": "iacziijjb6ily9niawef", "uuid": "aa9cd573-d098-d8cf-4d92-f5599534bca1", "entity_def_id": "organization", "value": "CARMAT"}, {"permalink": "beam-therapeutics", "image_id": "xvevgyb2mnmgejcyo3jt", "uuid": "4790901f-c38a-46a2-b60d-5d9123dec336", "entity_def_id": "organization", "value": "Beam Therapeutics"}], "org_funding_total": {"value_usd": 143814679344, "currency": "USD", "value": 143814679344}, "org_num_investors": 3528}, {"org_num": 909, "queries": {"person": [{"field_id": "location_identifiers", "operator_id": "includes", "values": ["090db99d-13e7-455a-a0e4-95cd21211c92"], "type": "predicate"}, {"field_id": "rank_person", "operator_id": "lte", "values": [1300000], "type": "predicate"}, {"collection_id": "organization.has_primary_organization.forward", "query": [{"field_id": "facet_ids", "operator_id": "includes", "values": ["company"], "type": "predicate"}, {"field_id": "location_identifiers", "operator_id": "includes", "values": ["090db99d-13e7-455a-a0e4-95cd21211c92"], "type": "predicate"}, {"field_id": "revenue_range", "operator_id": "includes", "values": ["r_00000000", "r_00001000", "r_00010000", "r_00050000", "r_00100000"], "type": "predicate"}, {"field_id": "funding_stage", "operator_id": "eq", "values": ["ipo"], "type": "predicate"}, {"field_id": "operating_status", "operator_id": "eq", "values": ["active"], "type": "predicate"}], "type": "sub_query"}], "organization": [{"field_id": "facet_ids", "operator_id": "includes", "values": ["company"], "type": "predicate"}, {"field_id": "location_identifiers", "operator_id": "includes", "values": ["090db99d-13e7-455a-a0e4-95cd21211c92"], "type": "predicate"}, {"field_id": "revenue_range", "operator_id": "includes", "values": ["r_00000000", "r_00001000", "r_00010000", "r_00050000", "r_00100000"], "type": "predicate"}, {"field_id": "funding_stage", "operator_id": "eq", "values": ["ipo"], "type": "predicate"}, {"field_id": "operating_status", "operator_id": "eq", "values": ["active"], "type": "predicate"}], "event": [{"field_id": "location_identifiers", "operator_id": "includes", "values": ["090db99d-13e7-455a-a0e4-95cd21211c92"], "type": "predicate"}, {"collection_id": "principal.has_event.forward", "query": [{"field_id": "facet_ids", "operator_id": "includes", "values": ["company"], "type": "predicate"}, {"field_id": "revenue_range", "operator_id": "includes", "values": ["r_00000000", "r_00001000", "r_00010000", "r_00050000", "r_00100000"], "type": "predicate"}, {"field_id": "funding_stage", "operator_id": "eq", "values": ["ipo"], "type": "predicate"}, {"field_id": "operating_status", "operator_id": "eq", "values": ["active"], "type": "predicate"}], "type": "sub_query"}]}, "identifier": {"permalink": "southern-us-public-companies-less-than-500m-in-revenue", "image_id": "glwyqmwxczzo9gezpyoq", "uuid": "722784c0-6b24-43c5-b613-e3545fbf63e9", "entity_def_id": "hub", "value": "Southern US Public Companies With Less Than $500M in Revenue"}, "org_identifiers": [{"permalink": "microstrategy", "image_id": "glwyqmwxczzo9gezpyoq", "uuid": "384a85e4-7be9-663d-3a17-ecd9ec360f23", "entity_def_id": "organization", "value": "MicroStrategy"}, {"permalink": "main-street-capital", "image_id": "v1459198507/xkivp6n619p7zvjzgdlc.png", "uuid": "a2fc8fbe-32e1-3219-a3a8-665ae83f7243", "entity_def_id": "organization", "value": "Main Street Capital"}, {"permalink": "longeveron", "image_id": "b7btjazs0ijnppnl3buq", "uuid": "4723d26a-9bbf-49c5-9ec6-b7e620723c02", "entity_def_id": "organization", "value": "Longeveron"}, {"permalink": "trust-stamp", "image_id": "v1475818738/u0ecyv65dkkoullzwfms.png", "uuid": "47bae1fb-0bd7-4eca-22fa-c542c576187f", "entity_def_id": "organization", "value": "Trust Stamp"}, {"permalink": "abacus-life", "image_id": "oseef8aqiip2swoccgdt", "uuid": "da47c213-4a11-4841-b788-56d9d1e96c88", "entity_def_id": "organization", "value": "Abacus Life"}, {"permalink": "ast-spacemobile", "image_id": "ussry0g1gufmmq4h7fpw", "uuid": "68c1b996-c37f-4663-9a8d-5e180bac356f", "entity_def_id": "organization", "value": "AST SpaceMobile"}, {"permalink": "ionq-inc", "image_id": "ioz8adoqarm3dcoovo2w", "uuid": "9caa6135-6881-6ad6-9e0f-f112e87dd455", "entity_def_id": "organization", "value": "IonQ"}, {"permalink": "luminar-technologies", "image_id": "fpbzsyzjmlegyvqga7ix", "uuid": "d94f8172-5a0b-624a-ee11-e752fb561c59", "entity_def_id": "organization", "value": "Luminar"}], "org_funding_total": {"value_usd": 94558044913, "currency": "USD", "value": 94558044913}, "org_num_investors": 1472}, {"org_num": 9610, "queries": {"person": [{"field_id": "location_identifiers", "operator_id": "includes", "values": ["090db99d-13e7-455a-a0e4-95cd21211c92"], "type": "predicate"}, {"field_id": "rank_person", "operator_id": "lte", "values": [64000], "type": "predicate"}, {"collection_id": "organization.has_primary_organization.forward", "query": [{"field_id": "facet_ids", "operator_id": "includes", "values": ["company"], "type": "predicate"}, {"field_id": "location_identifiers", "operator_id": "includes", "values": ["090db99d-13e7-455a-a0e4-95cd21211c92"], "type": "predicate"}, {"field_id": "operating_status", "operator_id": "eq", "values": ["active"], "type": "predicate"}, {"field_id": "rank_org", "operator_id": "lte", "values": [100000], "type": "predicate"}], "type": "sub_query"}], "organization": [{"field_id": "facet_ids", "operator_id": "includes", "values": ["company"], "type": "predicate"}, {"field_id": "location_identifiers", "operator_id": "includes", "values": ["090db99d-13e7-455a-a0e4-95cd21211c92"], "type": "predicate"}, {"field_id": "operating_status", "operator_id": "eq", "values": ["active"], "type": "predicate"}, {"field_id": "rank_org", "operator_id": "lte", "values": [100000], "type": "predicate"}], "event": [{"field_id": "location_identifiers", "operator_id": "includes", "values": ["090db99d-13e7-455a-a0e4-95cd21211c92"], "type": "predicate"}, {"collection_id": "principal.has_event.forward", "query": [{"field_id": "facet_ids", "operator_id": "includes", "values": ["company"], "type": "predicate"}, {"field_id": "operating_status", "operator_id": "eq", "values": ["active"], "type": "predicate"}], "type": "sub_query"}]}, "identifier": {"permalink": "southern-us-companies", "image_id": "cdtcj3oby93byve6rkat", "uuid": "6b1bb078-fcaf-4f7e-bd46-5f2e3448cf86", "entity_def_id": "hub", "value": "Southern US Companies (Top 10K)"}, "org_identifiers": [{"permalink": "humana", "image_id": "cdtcj3oby93byve6rkat", "uuid": "fae63b63-e7ce-b77d-5adb-1a8f6c270bb8", "entity_def_id": "organization", "value": "Humana"}, {"permalink": "tesla-motors", "image_id": "dj8rndg9wkqkpgvplvzi", "uuid": "a367b036-5952-5435-7541-ad7ee8869e24", "entity_def_id": "organization", "value": "Tesla"}, {"permalink": "bank-of-america", "image_id": "v1488030279/fkmjioyl8kk3g02p71ii.png", "uuid": "a7c69d60-5083-08ef-937b-6cef93a9728c", "entity_def_id": "organization", "value": "Bank of America"}, {"permalink": "hig-capital", "image_id": "v1467752476/o6hkf5vaixpyn9wvj0an.png", "uuid": "0d2ee297-1265-5001-4fd8-e9b890cecbdc", "entity_def_id": "organization", "value": "H.I.G. Capital"}, {"permalink": "saronic", "image_id": "exjcoyaqvsn9dqgpd8es", "uuid": "754cd68c-e834-4491-8146-c1f26278800d", "entity_def_id": "organization", "value": "Saronic"}, {"permalink": "thyme-care", "image_id": "snnoqzy91qqsoygl626d", "uuid": "aa535025-2041-4755-87ff-c2ce2bdd6388", "entity_def_id": "organization", "value": "Thyme Care"}, {"permalink": "cart-com", "image_id": "b8whdeqrl79w8i43w9sj", "uuid": "355272b6-fbea-4c68-883c-e14b3632d485", "entity_def_id": "organization", "value": "Cart.com"}, {"permalink": "cyble", "image_id": "yuqzhdjcatpxbvxmh93y", "uuid": "e92c942f-e4f9-443f-bb1d-1ef2e93c50f8", "entity_def_id": "organization", "value": "Cyble"}], "org_funding_total": {"value_usd": 1016384430063, "currency": "USD", "value": 1016384430063}, "org_num_investors": 34973}], "org_similarity_org_list": [{"identifier": {"uuid": "5af0682f-a025-e19d-bff4-3bdade524e1f", "value": "Innovent Biologics", "image_id": "ij8gtcyddvos1cbzrxbr", "permalink": "innovent-biologics", "entity_def_id": "organization"}}, {"identifier": {"uuid": "99cdcfe0-c689-9f42-c38a-1eb03709810b", "value": "Soligenix", "image_id": "junnkiaga8xjn2epgnpk", "permalink": "soligenix", "entity_def_id": "organization"}}, {"identifier": {"uuid": "fdc5b685-1721-0d4d-3095-2624539281c3", "value": "Celator Pharmaceuticals", "image_id": "v1397191552/6da55f4e3a591e501fa5913c351caf7e.gif", "permalink": "celator-pharmaceuticals", "entity_def_id": "organization"}}, {"identifier": {"uuid": "fe36ff01-b4ba-e623-a066-ef73c922a96f", "value": "Salix Pharmaceuticals", "image_id": "v1397181178/6aa57399ee4959f8894776ebec9a2bc4.jpg", "permalink": "salix-pharmaceuticals", "entity_def_id": "organization"}}], "investors_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "funds_list": [], "key_employee_change_list": [], "alumni_image_list": [], "frequently_asked_questions_total_funding": {"funding_total": {"value": 21181033, "currency": "USD", "value_usd": 21181033}, "identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "news_insight_text_link": {}, "exits_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "bombora_surge_list": [], "diversity_spotlight_investments_list": [], "builtwith_tech_used_list": [{"identifier": {"uuid": "2f6cffdd-6438-400e-9512-692a21e184d8", "value": "IPhone / Mobile Compatible", "entity_def_id": "builtwith_technology"}, "technology_category": ["mobile"], "num_companies_using": 999613}, {"identifier": {"uuid": "983394a8-d4ee-4af3-89ba-ae3a204dc982", "value": "Viewport Meta", "entity_def_id": "builtwith_technology"}, "technology_category": ["mobile"], "num_companies_using": 999589}, {"identifier": {"uuid": "745d7435-4344-4c2d-80ac-3866e0186e2d", "value": "Google Maps", "entity_def_id": "builtwith_technology"}, "technology_category": ["mapping"], "num_companies_using": 499980}, {"identifier": {"uuid": "a668208a-5cf7-40a9-8135-b2737d2ed79b", "value": "Amazon", "entity_def_id": "builtwith_technology"}, "technology_category": ["hosting"], "num_companies_using": 465954}, {"identifier": {"uuid": "cf3e732d-2ada-4f4e-94af-faa2edb426d5", "value": "IPv6", "entity_def_id": "builtwith_technology"}, "technology_category": ["server"], "num_companies_using": 359702}, {"identifier": {"uuid": "5ba219c3-617b-402a-8ddd-10af8bf8ecd8", "value": "Cloudflare Hosting", "entity_def_id": "builtwith_technology"}, "technology_category": ["hosting"], "num_companies_using": 319246}, {"identifier": {"uuid": "9ab829f3-a35a-4500-b627-76ee9925c64b", "value": "Google Apps for Business", "entity_def_id": "builtwith_technology"}, "technology_category": ["mx"], "num_companies_using": 198308}, {"identifier": {"uuid": "ac4b3ca2-7ee5-4c64-82ff-2e57d4e8deed", "value": "Google Maps API", "entity_def_id": "builtwith_technology"}, "technology_category": ["mapping"], "num_companies_using": 187211}, {"identifier": {"uuid": "70f4762f-11eb-48f1-8d0e-2ebdaca5f9e4", "value": "Cloudflare CDN", "entity_def_id": "builtwith_technology"}, "technology_category": ["cdn"], "num_companies_using": 163708}, {"identifier": {"uuid": "35fb33ce-1695-49d3-9de5-1f1fd5660f01", "value": "Cloudflare", "entity_def_id": "builtwith_technology"}, "technology_category": ["cdn"], "num_companies_using": 144813}], "funding_rounds_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}, "funding_total": {"value": 21181033, "currency": "USD", "value_usd": 21181033}, "num_funding_rounds": 4, "last_funding_type": "post_ipo_equity", "last_funding_at": "2021-05-03"}, "org_similarity_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}, "insight_similar_orgs": "Amarillo Biosciences, Soligenix, Innovent Biologics, Celator Pharmaceuticals, and Salix Pharmaceuticals operate in the biopharmaceutical industry. Soligenix and Innovent Biologics focus on developing vaccines and therapeutics, while Celator Pharmaceuticals specializes in cancer treatments using a unique drug ratio technology platform. Salix Pharmaceuticals is dedicated to gastrointestinal disorder prevention and treatment."}, "org_similarity_list": [{"target_num_contacts": 16, "source": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}, "source_num_contacts": 6, "identifier": {"uuid": "e3ff1c42-7e8f-4670-83dc-e36be5d34f2b"}, "source_locations": [{"uuid": "6116b275-8924-0d89-bc8f-9a8afeb8caaa", "value": "Amarillo", "permalink": "amarillo-texas", "entity_def_id": "location", "location_type": "city"}, {"uuid": "54e9e76a-1847-d137-00a7-ed1aab624b78", "value": "Texas", "permalink": "texas-united-states", "entity_def_id": "location", "location_type": "region"}, {"uuid": "f110fca2-1055-99f6-996d-011c198b3928", "value": "United States", "permalink": "united-states", "entity_def_id": "location", "location_type": "country"}, {"uuid": "b25caef9-a1b8-3a5d-6232-93b2dfb6a1d1", "value": "North America", "permalink": "north-america", "entity_def_id": "location", "location_type": "continent"}], "uuid": "e3ff1c42-7e8f-4670-83dc-e36be5d34f2b", "score": 0.996178, "target_locations": [{"uuid": "2a59d004-8542-8aaf-d7a5-3f68c59121a5", "value": "Princeton", "permalink": "princeton-new-jersey", "entity_def_id": "location", "location_type": "city"}, {"uuid": "625bdda2-0f43-8348-c41c-7654bfbecd02", "value": "New Jersey", "permalink": "new-jersey-united-states", "entity_def_id": "location", "location_type": "region"}, {"uuid": "f110fca2-1055-99f6-996d-011c198b3928", "value": "United States", "permalink": "united-states", "entity_def_id": "location", "location_type": "country"}, {"uuid": "b25caef9-a1b8-3a5d-6232-93b2dfb6a1d1", "value": "North America", "permalink": "north-america", "entity_def_id": "location", "location_type": "continent"}], "target_short_description": "Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.", "target_categories": [{"uuid": "16ad1d6c-c7ee-b6b5-701d-32c79a19dfae", "value": "Biopharma", "permalink": "biopharma", "entity_def_id": "category"}, {"uuid": "58842728-7ab9-5bd1-bb67-e8e55f6520a0", "value": "Biotechnology", "permalink": "biotechnology", "entity_def_id": "category"}, {"uuid": "3f21415b-5784-6be6-3722-eb189190b7cd", "value": "Health Care", "permalink": "health-care", "entity_def_id": "category"}, {"uuid": "9126275d-d470-1524-02f4-93d481721a6e", "value": "Medical", "permalink": "medical", "entity_def_id": "category"}], "source_num_employees_enum": "c_00001_00010", "target_location_groups": [{"uuid": "6c6b9ca5-966a-448b-8480-29b5a753f9ee", "value": "East Coast", "permalink": "east-coast-united-states", "entity_def_id": "location", "location_type": "group"}, {"uuid": "75989641-ef66-456e-b7cd-dfa57b34e881", "value": "Northeastern US", "permalink": "northeastern-united-states", "entity_def_id": "location", "location_type": "group"}], "source_short_description": "Amarillo Biosciences is a specialty biopharmaceutical company developing a patented formulation of interferon-alpha.", "target": {"uuid": "99cdcfe0-c689-9f42-c38a-1eb03709810b", "value": "Soligenix", "image_id": "junnkiaga8xjn2epgnpk", "permalink": "soligenix", "entity_def_id": "organization"}, "source_categories": [{"uuid": "16ad1d6c-c7ee-b6b5-701d-32c79a19dfae", "value": "Biopharma", "permalink": "biopharma", "entity_def_id": "category"}, {"uuid": "58842728-7ab9-5bd1-bb67-e8e55f6520a0", "value": "Biotechnology", "permalink": "biotechnology", "entity_def_id": "category"}, {"uuid": "9126275d-d470-1524-02f4-93d481721a6e", "value": "Medical", "permalink": "medical", "entity_def_id": "category"}], "source_location_groups": [{"uuid": "090db99d-13e7-455a-a0e4-95cd21211c92", "value": "Southern US", "permalink": "southern-united-states", "entity_def_id": "location", "location_type": "group"}], "target_num_employees_enum": "c_00011_00050", "reasons": ["category"]}, {"target_num_contacts": 6, "source": {"uuid": "5af0682f-a025-e19d-bff4-3bdade524e1f", "value": "Innovent Biologics", "image_id": "ij8gtcyddvos1cbzrxbr", "permalink": "innovent-biologics", "entity_def_id": "organization"}, "source_num_contacts": 58, "identifier": {"uuid": "46cbaa62-fad9-439b-9116-197cb2b9f7a1"}, "source_locations": [{"uuid": "c8a26584-26ed-6c1f-ceee-00232f8ad56c", "value": "Suzhou", "permalink": "suzhou-jiangsu", "entity_def_id": "location", "location_type": "city"}, {"uuid": "1cc3b31e-da5c-a9ee-8cbf-403199b8d764", "value": "Jiangsu", "permalink": "jiangsu-china", "entity_def_id": "location", "location_type": "region"}, {"uuid": "500afaba-4645-0121-d7b8-99327c7aaa07", "value": "China", "permalink": "china-500a", "entity_def_id": "location", "location_type": "country"}, {"uuid": "b41404d2-8ecc-caf5-1268-8fdd3afe73ee", "value": "Asia", "permalink": "asia", "entity_def_id": "location", "location_type": "continent"}], "uuid": "46cbaa62-fad9-439b-9116-197cb2b9f7a1", "score": 0.99550563, "target_locations": [{"uuid": "6116b275-8924-0d89-bc8f-9a8afeb8caaa", "value": "Amarillo", "permalink": "amarillo-texas", "entity_def_id": "location", "location_type": "city"}, {"uuid": "54e9e76a-1847-d137-00a7-ed1aab624b78", "value": "Texas", "permalink": "texas-united-states", "entity_def_id": "location", "location_type": "region"}, {"uuid": "f110fca2-1055-99f6-996d-011c198b3928", "value": "United States", "permalink": "united-states", "entity_def_id": "location", "location_type": "country"}, {"uuid": "b25caef9-a1b8-3a5d-6232-93b2dfb6a1d1", "value": "North America", "permalink": "north-america", "entity_def_id": "location", "location_type": "continent"}], "target_short_description": "Amarillo Biosciences is a specialty biopharmaceutical company developing a patented formulation of interferon-alpha.", "target_categories": [{"uuid": "16ad1d6c-c7ee-b6b5-701d-32c79a19dfae", "value": "Biopharma", "permalink": "biopharma", "entity_def_id": "category"}, {"uuid": "58842728-7ab9-5bd1-bb67-e8e55f6520a0", "value": "Biotechnology", "permalink": "biotechnology", "entity_def_id": "category"}, {"uuid": "9126275d-d470-1524-02f4-93d481721a6e", "value": "Medical", "permalink": "medical", "entity_def_id": "category"}], "source_num_employees_enum": "c_05001_10000", "target_location_groups": [{"uuid": "090db99d-13e7-455a-a0e4-95cd21211c92", "value": "Southern US", "permalink": "southern-united-states", "entity_def_id": "location", "location_type": "group"}], "source_short_description": "Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.", "target": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}, "source_categories": [{"uuid": "16ad1d6c-c7ee-b6b5-701d-32c79a19dfae", "value": "Biopharma", "permalink": "biopharma", "entity_def_id": "category"}, {"uuid": "58842728-7ab9-5bd1-bb67-e8e55f6520a0", "value": "Biotechnology", "permalink": "biotechnology", "entity_def_id": "category"}, {"uuid": "e811671c-168d-1fd2-36e5-df4e08a09f7c", "value": "Manufacturing", "permalink": "manufacturing", "entity_def_id": "category"}], "source_location_groups": [{"uuid": "2d80faa6-8493-4565-887f-f18b0b9f7d03", "value": "Asia-Pacific (APAC)", "permalink": "asia-pacific", "entity_def_id": "location", "location_type": "group"}], "target_num_employees_enum": "c_00001_00010", "reasons": ["category"]}, {"target_num_contacts": 6, "source": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}, "source_num_contacts": 6, "identifier": {"uuid": "a890cbf9-2975-4355-bf68-278529794f8e"}, "source_locations": [{"uuid": "6116b275-8924-0d89-bc8f-9a8afeb8caaa", "value": "Amarillo", "permalink": "amarillo-texas", "entity_def_id": "location", "location_type": "city"}, {"uuid": "54e9e76a-1847-d137-00a7-ed1aab624b78", "value": "Texas", "permalink": "texas-united-states", "entity_def_id": "location", "location_type": "region"}, {"uuid": "f110fca2-1055-99f6-996d-011c198b3928", "value": "United States", "permalink": "united-states", "entity_def_id": "location", "location_type": "country"}, {"uuid": "b25caef9-a1b8-3a5d-6232-93b2dfb6a1d1", "value": "North America", "permalink": "north-america", "entity_def_id": "location", "location_type": "continent"}], "uuid": "a890cbf9-2975-4355-bf68-278529794f8e", "score": 0.99432594, "target_locations": [{"uuid": "2a59d004-8542-8aaf-d7a5-3f68c59121a5", "value": "Princeton", "permalink": "princeton-new-jersey", "entity_def_id": "location", "location_type": "city"}, {"uuid": "625bdda2-0f43-8348-c41c-7654bfbecd02", "value": "New Jersey", "permalink": "new-jersey-united-states", "entity_def_id": "location", "location_type": "region"}, {"uuid": "f110fca2-1055-99f6-996d-011c198b3928", "value": "United States", "permalink": "united-states", "entity_def_id": "location", "location_type": "country"}, {"uuid": "b25caef9-a1b8-3a5d-6232-93b2dfb6a1d1", "value": "North America", "permalink": "north-america", "entity_def_id": "location", "location_type": "continent"}], "target_short_description": "Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.", "target_categories": [{"uuid": "16ad1d6c-c7ee-b6b5-701d-32c79a19dfae", "value": "Biopharma", "permalink": "biopharma", "entity_def_id": "category"}, {"uuid": "58842728-7ab9-5bd1-bb67-e8e55f6520a0", "value": "Biotechnology", "permalink": "biotechnology", "entity_def_id": "category"}, {"uuid": "3f21415b-5784-6be6-3722-eb189190b7cd", "value": "Health Care", "permalink": "health-care", "entity_def_id": "category"}, {"uuid": "8c1b0c58-4cc6-5d0a-0208-f656f91e4c82", "value": "Health Diagnostics", "permalink": "health-diagnostics", "entity_def_id": "category"}, {"uuid": "9126275d-d470-1524-02f4-93d481721a6e", "value": "Medical", "permalink": "medical", "entity_def_id": "category"}, {"uuid": "0ae5c1be-64b1-a9fe-6c76-076285d2380f", "value": "Pharmaceutical", "permalink": "pharmaceutical", "entity_def_id": "category"}], "source_num_employees_enum": "c_00001_00010", "target_location_groups": [{"uuid": "6c6b9ca5-966a-448b-8480-29b5a753f9ee", "value": "East Coast", "permalink": "east-coast-united-states", "entity_def_id": "location", "location_type": "group"}, {"uuid": "75989641-ef66-456e-b7cd-dfa57b34e881", "value": "Northeastern US", "permalink": "northeastern-united-states", "entity_def_id": "location", "location_type": "group"}], "source_short_description": "Amarillo Biosciences is a specialty biopharmaceutical company developing a patented formulation of interferon-alpha.", "target": {"uuid": "fdc5b685-1721-0d4d-3095-2624539281c3", "value": "Celator Pharmaceuticals", "image_id": "v1397191552/6da55f4e3a591e501fa5913c351caf7e.gif", "permalink": "celator-pharmaceuticals", "entity_def_id": "organization"}, "source_categories": [{"uuid": "16ad1d6c-c7ee-b6b5-701d-32c79a19dfae", "value": "Biopharma", "permalink": "biopharma", "entity_def_id": "category"}, {"uuid": "58842728-7ab9-5bd1-bb67-e8e55f6520a0", "value": "Biotechnology", "permalink": "biotechnology", "entity_def_id": "category"}, {"uuid": "9126275d-d470-1524-02f4-93d481721a6e", "value": "Medical", "permalink": "medical", "entity_def_id": "category"}], "source_location_groups": [{"uuid": "090db99d-13e7-455a-a0e4-95cd21211c92", "value": "Southern US", "permalink": "southern-united-states", "entity_def_id": "location", "location_type": "group"}], "target_num_employees_enum": "c_00011_00050", "reasons": ["category"]}, {"target_num_contacts": 676, "source": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}, "source_num_contacts": 6, "identifier": {"uuid": "c16cee52-7156-4ce5-9c68-da359bb4ae5c"}, "source_locations": [{"uuid": "6116b275-8924-0d89-bc8f-9a8afeb8caaa", "value": "Amarillo", "permalink": "amarillo-texas", "entity_def_id": "location", "location_type": "city"}, {"uuid": "54e9e76a-1847-d137-00a7-ed1aab624b78", "value": "Texas", "permalink": "texas-united-states", "entity_def_id": "location", "location_type": "region"}, {"uuid": "f110fca2-1055-99f6-996d-011c198b3928", "value": "United States", "permalink": "united-states", "entity_def_id": "location", "location_type": "country"}, {"uuid": "b25caef9-a1b8-3a5d-6232-93b2dfb6a1d1", "value": "North America", "permalink": "north-america", "entity_def_id": "location", "location_type": "continent"}], "uuid": "c16cee52-7156-4ce5-9c68-da359bb4ae5c", "score": 0.9934552, "target_locations": [{"uuid": "77a3de20-7496-7e3e-134f-10f790dca0cc", "value": "Raleigh", "permalink": "raleigh-north-carolina", "entity_def_id": "location", "location_type": "city"}, {"uuid": "f967e667-32ce-6748-d7e0-75e756617ccd", "value": "North Carolina", "permalink": "north-carolina-united-states", "entity_def_id": "location", "location_type": "region"}, {"uuid": "f110fca2-1055-99f6-996d-011c198b3928", "value": "United States", "permalink": "united-states", "entity_def_id": "location", "location_type": "country"}, {"uuid": "b25caef9-a1b8-3a5d-6232-93b2dfb6a1d1", "value": "North America", "permalink": "north-america", "entity_def_id": "location", "location_type": "continent"}], "target_short_description": "Salix Pharmaceuticals is a specialty pharmaceutical company\u00a0focused on the\u00a0prevention and treatment of gastrointestinal disorders.", "target_categories": [{"uuid": "58842728-7ab9-5bd1-bb67-e8e55f6520a0", "value": "Biotechnology", "permalink": "biotechnology", "entity_def_id": "category"}, {"uuid": "3f21415b-5784-6be6-3722-eb189190b7cd", "value": "Health Care", "permalink": "health-care", "entity_def_id": "category"}, {"uuid": "9126275d-d470-1524-02f4-93d481721a6e", "value": "Medical", "permalink": "medical", "entity_def_id": "category"}, {"uuid": "0ae5c1be-64b1-a9fe-6c76-076285d2380f", "value": "Pharmaceutical", "permalink": "pharmaceutical", "entity_def_id": "category"}], "source_num_employees_enum": "c_00001_00010", "target_location_groups": [{"uuid": "2f1b0986-a0fa-4232-a48e-86401061a98b", "value": "Research Triangle", "permalink": "research-triangle-north-carolina", "entity_def_id": "location", "location_type": "group"}, {"uuid": "6c6b9ca5-966a-448b-8480-29b5a753f9ee", "value": "East Coast", "permalink": "east-coast-united-states", "entity_def_id": "location", "location_type": "group"}, {"uuid": "090db99d-13e7-455a-a0e4-95cd21211c92", "value": "Southern US", "permalink": "southern-united-states", "entity_def_id": "location", "location_type": "group"}], "source_short_description": "Amarillo Biosciences is a specialty biopharmaceutical company developing a patented formulation of interferon-alpha.", "target": {"uuid": "fe36ff01-b4ba-e623-a066-ef73c922a96f", "value": "Salix Pharmaceuticals", "image_id": "v1397181178/6aa57399ee4959f8894776ebec9a2bc4.jpg", "permalink": "salix-pharmaceuticals", "entity_def_id": "organization"}, "source_categories": [{"uuid": "16ad1d6c-c7ee-b6b5-701d-32c79a19dfae", "value": "Biopharma", "permalink": "biopharma", "entity_def_id": "category"}, {"uuid": "58842728-7ab9-5bd1-bb67-e8e55f6520a0", "value": "Biotechnology", "permalink": "biotechnology", "entity_def_id": "category"}, {"uuid": "9126275d-d470-1524-02f4-93d481721a6e", "value": "Medical", "permalink": "medical", "entity_def_id": "category"}], "source_location_groups": [{"uuid": "090db99d-13e7-455a-a0e4-95cd21211c92", "value": "Southern US", "permalink": "southern-united-states", "entity_def_id": "location", "location_type": "group"}], "target_num_employees_enum": "c_00501_01000", "reasons": ["category", "funding_stage"]}], "acquisitions_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "advisors_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "acquisitions_list": [], "alumni_headline": {}, "exits_headline": {}, "investments_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "acquired_by_fields": {}, "research_insight_text_link": {}, "sub_organizations_headline": {}, "layoff_list": [], "overview_school_fields": {}, "bombora_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "semrush_rank_headline": {}, "frequently_asked_questions_latest_funding_round": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}, "last_funding_at": "2021-05-03", "last_funding_type": "post_ipo_equity", "num_funding_rounds": 4}, "contacts": {"num_contact_emails": 11, "num_contact_phones": 3, "num_contacts": 6}, "alumni_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "apptopia_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "diversity_spotlight_investments_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "contact_fields": {"contact_email": "ABI@amarbio.com", "phone_number": "806-376-1741"}, "social_fields": {"linkedin": {"value": "https://www.linkedin.com/company/amarillo-biosciences-inc"}}, "investments_headline": {}, "investment_thesis": {"properties": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}}, "sub_organizations_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "overview_description": {"description": "Amarillo Biosciences is a specialty biopharmaceutical company developing a patented formulation of interferon-alpha that's given orally in low doses, making it safer and less expensive than current injectable formulations. The company engaged in the discovery and development of novel biopharmaceuticals, technologically innovative medical treatments, and specialty consumer products. \n\nAmarillo Biosciences also focuses on the advancement of low-dose oral interferon as a therapeutic treatment for numerous indications such as thrombocytopenia, Sj\u00f6gren's syndrome, hepatitis C virus (HCV) and influenza, a potential multi-million dollar market opportunity. Low-dose oral interferon has been shown to have fewer side effects and is less costly than high-dose injectable interferon. \n\nThe company's goal is to introduce cutting edge products that actively stimulate and rejuvenate the human body to combat disease and enhance the ability to heal."}, "current_employees_featured_order_field": [{"person_identifier": {"uuid": "f52865e0-cc74-f4d4-b1b1-5f72653b14be", "value": "Bernard H. Cohen", "permalink": "bernard-h-cohen", "entity_def_id": "person"}, "identifier": {"uuid": "0db6062a-0e3f-c609-f2cb-5418fc674629", "value": "Bernard H. Cohen Vice President and CFO @ Amarillo Biosciences", "permalink": "bernard-h-cohen-executive-amarillo-biosciences--0db6062a", "entity_def_id": "job"}, "title": "Vice President and CFO"}, {"person_identifier": {"uuid": "47d2509e-0e84-2413-edc0-2fe3dcf01552", "value": "Joseph Cummins", "permalink": "joseph-cummins", "entity_def_id": "person"}, "identifier": {"uuid": "1a2f6d9f-f5e6-5aa4-93e9-a5535b276ab2", "value": "Joseph Cummins President @ Amarillo Biosciences", "permalink": "joseph-cummins-executive-amarillo-biosciences--1a2f6d9f", "entity_def_id": "job"}, "title": "President"}], "company_about_fields2": {"website": {"value": "http://amarbio.com"}, "ipo_status": "delisted", "num_employees_enum": "c_00001_00010", "last_funding_type": "post_ipo_equity", "location_identifiers": [{"uuid": "6116b275-8924-0d89-bc8f-9a8afeb8caaa", "value": "Amarillo", "permalink": "amarillo-texas", "entity_def_id": "location", "location_type": "city"}, {"uuid": "54e9e76a-1847-d137-00a7-ed1aab624b78", "value": "Texas", "permalink": "texas-united-states", "entity_def_id": "location", "location_type": "region"}, {"uuid": "f110fca2-1055-99f6-996d-011c198b3928", "value": "United States", "permalink": "united-states", "entity_def_id": "location", "location_type": "country"}, {"uuid": "b25caef9-a1b8-3a5d-6232-93b2dfb6a1d1", "value": "North America", "permalink": "north-america", "entity_def_id": "location", "location_type": "continent"}], "rank_org_company": 86118}, "sub_organizations_image_list": [], "frequently_asked_questions_headquarters_location": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}, "location_identifiers": [{"uuid": "6116b275-8924-0d89-bc8f-9a8afeb8caaa", "value": "Amarillo", "permalink": "amarillo-texas", "entity_def_id": "location", "location_type": "city"}, {"uuid": "54e9e76a-1847-d137-00a7-ed1aab624b78", "value": "Texas", "permalink": "texas-united-states", "entity_def_id": "location", "location_type": "region"}, {"uuid": "f110fca2-1055-99f6-996d-011c198b3928", "value": "United States", "permalink": "united-states", "entity_def_id": "location", "location_type": "country"}, {"uuid": "b25caef9-a1b8-3a5d-6232-93b2dfb6a1d1", "value": "North America", "permalink": "north-america", "entity_def_id": "location", "location_type": "continent"}]}, "investors_headline": {}, "investor_insight_text_link": {}, "ipo_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}, "stock_link": {"label": "OTCBB:AMARQ", "value": "https://www.google.com/finance?q=OTCBB:AMARQ"}, "went_public_on": "2003-01-10"}, "ipqwery_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}, "ipqwery_num_patent_granted": 6, "ipqwery_num_trademark_registered": 0, "ipqwery_popular_patent_category": "a61"}, "siftery_product_list": [{"product_identifier": {"uuid": "44fbb3b4-e7da-4a08-b981-83f46b8b2f01", "value": "HTML5", "image_id": "siftery/siftery_logo_prNc7nA_qm8_k5", "entity_def_id": "siftery_product"}, "identifier": {"uuid": "e29e7632-0816-46b0-891b-71235c950b43"}, "uuid": "e29e7632-0816-46b0-891b-71235c950b43", "product_num_customers": 439507, "status": "using"}, {"product_identifier": {"uuid": "805f03a3-ee62-4c9e-8457-1a5f564b8239", "value": "jQuery", "image_id": "siftery/siftery_logo_prViuoE4t3fDhh", "entity_def_id": "siftery_product"}, "identifier": {"uuid": "a51be2e5-f875-4c1e-bd69-52766b0ecb82"}, "uuid": "a51be2e5-f875-4c1e-bd69-52766b0ecb82", "product_num_customers": 361334, "status": "not_using"}, {"product_identifier": {"uuid": "d50e90bf-6165-4df9-aa0d-c87ef00f9002", "value": "Google Fonts", "image_id": "siftery/siftery_logo_preFJ8BUpXArcN", "entity_def_id": "siftery_product"}, "identifier": {"uuid": "106472cf-e912-4666-bb88-52db517664bd"}, "uuid": "106472cf-e912-4666-bb88-52db517664bd", "product_num_customers": 300445, "status": "using"}, {"product_identifier": {"uuid": "344a4034-da0b-4918-9c6b-11fd9b1e48b8", "value": "Vimeo", "image_id": "siftery/siftery_logo_prTux9uLV9SFjw", "entity_def_id": "siftery_product"}, "identifier": {"uuid": "4fdab382-2e6c-467c-96da-0056b04a28bf"}, "uuid": "4fdab382-2e6c-467c-96da-0056b04a28bf", "product_num_customers": 226195, "status": "using"}, {"product_identifier": {"uuid": "a4cae353-b206-4eb3-8719-e8713534dd72", "value": "Google Workspace", "image_id": "siftery/siftery_logo_prle2szvkL3j4g", "entity_def_id": "siftery_product"}, "identifier": {"uuid": "7d330291-065b-45df-a72e-6dd6a66b409e"}, "uuid": "7d330291-065b-45df-a72e-6dd6a66b409e", "product_num_customers": 175277, "status": "using"}, {"product_identifier": {"uuid": "f1ed96f5-ca47-4923-8d30-c55e8bbdbd24", "value": "PHP", "image_id": "siftery/siftery_logo_prKZCdw9FMjTzR", "entity_def_id": "siftery_product"}, "identifier": {"uuid": "8b39e51f-57a6-4268-90ca-17a11d095015"}, "uuid": "8b39e51f-57a6-4268-90ca-17a11d095015", "product_num_customers": 161313, "status": "not_using"}, {"product_identifier": {"uuid": "89cec21b-759d-48a8-aa73-74132e1a6fd0", "value": "Apache Server", "image_id": "siftery/siftery_logo_prvrxOhb1ru2BC", "entity_def_id": "siftery_product"}, "identifier": {"uuid": "8e5ab2a2-06a0-4a7e-aae3-a5ec01196c9d"}, "uuid": "8e5ab2a2-06a0-4a7e-aae3-a5ec01196c9d", "product_num_customers": 152023, "status": "not_using"}, {"product_identifier": {"uuid": "e5bbe17f-8c04-4cf1-ac56-540c6361adfc", "value": "Bootstrap", "image_id": "siftery/siftery_logo_prwBYuId9rorux", "entity_def_id": "siftery_product"}, "identifier": {"uuid": "f1069eed-dde7-4b8b-8bde-419035f172fa"}, "uuid": "f1069eed-dde7-4b8b-8bde-419035f172fa", "product_num_customers": 146079, "status": "not_using"}, {"product_identifier": {"uuid": "75a119b8-1d35-4d72-9a3f-6a9ba5cc1dca", "value": "Google Drive", "image_id": "siftery/siftery_logo_pr04eJ1-Oop6gS", "entity_def_id": "siftery_product"}, "identifier": {"uuid": "001625b7-bc49-4181-9164-1f52886b7114"}, "uuid": "001625b7-bc49-4181-9164-1f52886b7114", "product_num_customers": 143830, "status": "using"}, {"product_identifier": {"uuid": "11a88714-4f91-4531-ab29-9fe295166bab", "value": "Google Maps API", "image_id": "siftery/siftery_logo_prKACaph8jvdBB", "entity_def_id": "siftery_product"}, "identifier": {"uuid": "cc564a7d-2a75-4a8c-a475-e4423d1f7655"}, "uuid": "cc564a7d-2a75-4a8c-a475-e4423d1f7655", "product_num_customers": 142652, "status": "using"}], "growth_knowledge": {"lookup": [], "properties": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "data": []}, "overview_fields_extended": {"location_group_identifiers": [{"uuid": "090db99d-13e7-455a-a0e4-95cd21211c92", "value": "Southern US", "permalink": "southern-united-states", "entity_def_id": "location", "location_type": "group"}], "aliases": ["Ainos, Inc."], "founded_on": {"value": "1984-01-01", "precision": "year"}, "founder_identifiers": [{"uuid": "47d2509e-0e84-2413-edc0-2fe3dcf01552", "value": "Joseph Cummins", "permalink": "joseph-cummins", "entity_def_id": "person"}], "operating_status": "active", "last_funding_type": "post_ipo_equity", "categories": [{"uuid": "16ad1d6c-c7ee-b6b5-701d-32c79a19dfae", "value": "Biopharma", "permalink": "biopharma", "entity_def_id": "category"}, {"uuid": "58842728-7ab9-5bd1-bb67-e8e55f6520a0", "value": "Biotechnology", "permalink": "biotechnology", "entity_def_id": "category"}, {"uuid": "9126275d-d470-1524-02f4-93d481721a6e", "value": "Medical", "permalink": "medical", "entity_def_id": "category"}], "legal_name": "Amarillo Biosciences, Inc."}, "bombora_attribution": {}, "semrush_location_list": [], "overview_investor_fields": {}, "investors_list": [], "siftery_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}, "siftery_num_products": 10}, "acquired_by_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "ipo_fields": {"delisted_on": {"value": "2014-12-16", "precision": "day"}, "stock_link": {"label": "OTCBB:AMARQ", "value": "https://www.google.com/finance?q=OTCBB:AMARQ"}, "went_public_on": "2003-01-10"}, "apptopia_app_overview_list_public": [], "trading_view": {}, "news_headline": {"num_articles": 2}, "current_employees_image_list": [{"identifier": {"uuid": "0db6062a-0e3f-c609-f2cb-5418fc674629", "value": "Bernard H. Cohen Vice President and CFO @ Amarillo Biosciences", "permalink": "bernard-h-cohen-executive-amarillo-biosciences--0db6062a", "entity_def_id": "job"}, "person_identifier": {"uuid": "f52865e0-cc74-f4d4-b1b1-5f72653b14be", "value": "Bernard H. Cohen", "permalink": "bernard-h-cohen", "entity_def_id": "person"}, "title": "Vice President and CFO"}, {"identifier": {"uuid": "1a2f6d9f-f5e6-5aa4-93e9-a5535b276ab2", "value": "Joseph Cummins President @ Amarillo Biosciences", "permalink": "joseph-cummins-executive-amarillo-biosciences--1a2f6d9f", "entity_def_id": "job"}, "person_identifier": {"uuid": "47d2509e-0e84-2413-edc0-2fe3dcf01552", "value": "Joseph Cummins", "permalink": "joseph-cummins", "entity_def_id": "person"}, "title": "President"}], "privco_summary_public": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "event_appearances_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "diversity_spotlight_investments_headline": {}, "frequently_asked_questions_investors": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "funding_rounds_list": [{"identifier": {"uuid": "e9d7f978-430c-4815-a21f-c5032034536a", "value": "Post-IPO Equity - Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences-post-ipo-equity--e9d7f978", "entity_def_id": "funding_round"}, "announced_on": "2021-05-03", "money_raised": {"value": 20000000, "currency": "USD", "value_usd": 20000000}}, {"identifier": {"uuid": "45cd6cac-3883-475c-8925-e5847594d2ad", "value": "Post-IPO Equity - Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences-post-ipo-equity--45cd6cac", "entity_def_id": "funding_round"}, "announced_on": "2017-12-19", "money_raised": {"value": 581033, "currency": "USD", "value_usd": 581033}}, {"identifier": {"uuid": "5e70f53f-c31d-045b-d520-d4e53204a841", "value": "Debt Financing - Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences-debt-financing--5e70f53f", "entity_def_id": "funding_round"}, "announced_on": "2016-04-07", "money_raised": {"value": 600000, "currency": "USD", "value_usd": 600000}}, {"identifier": {"uuid": "bdf8a881-8f75-b4b1-1608-56313407d880", "value": "Post-IPO Equity - Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences-post-ipo-equity--bdf8a881", "entity_def_id": "funding_round"}, "announced_on": "2008-06-03"}], "growth_insight_text_link": {}, "technology_highlights": {"builtwith_num_technologies_used": 14, "siftery_num_products": 10}, "funding_rounds_headline": {"funding_total": {"value": 21181033, "currency": "USD", "value_usd": 21181033}, "num_funding_rounds": 4}, "investments_list": [], "exits_image_list": [], "funds_headline": {}, "people_highlights": {"num_contacts": 6, "num_current_positions": 2}, "current_employees_headline": {"num_current_positions": 2}, "semrush_attribution": {}, "frequently_asked_questions_similar_companies": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "event_appearances_list": [], "current_employees_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}, "num_current_positions": 2}, "funds_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "aberdeen_summary": {"identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "overview_timeline": {"count": 8, "entities": [{"uuid": "e9d7f978-430c-4815-a21f-c5032034536a", "properties": {"identifier": {"uuid": "e9d7f978-430c-4815-a21f-c5032034536a", "value": "Post-IPO Equity - Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences-post-ipo-equity--e9d7f978", "entity_def_id": "funding_round"}, "activity_properties": {"money_raised": {"value": 20000000, "currency": "USD", "value_usd": 20000000}, "investment_type": "post_ipo_equity"}, "activity_date": "2021-05-03", "entity_def_id": "funding_round", "activity_entities": [{"role": "investee", "uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}]}}, {"uuid": "c5c2ee78-27d5-4104-9508-1234d37f99af", "properties": {"identifier": {"uuid": "c5c2ee78-27d5-4104-9508-1234d37f99af", "value": "Short Interest in Amarillo Biosciences Inc (OTCMKTS:AMAR) Increases By 100.0%", "entity_def_id": "press_reference"}, "activity_properties": {"url": {"value": "http://dlvr.it/RhZd59"}, "title": "Short Interest in Amarillo Biosciences Inc (OTCMKTS:AMAR) Increases By 100.0%", "publisher": "techinvestornews.com"}, "activity_date": "2020-09-29", "entity_def_id": "press_reference", "activity_entities": [{"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}]}}, {"uuid": "46bdd56b-3cab-4edb-9741-b1a74e45e568", "properties": {"identifier": {"uuid": "46bdd56b-3cab-4edb-9741-b1a74e45e568", "value": "RSV and HPIV-3 Infections Drug Development: 2018 Pipeline Review", "entity_def_id": "press_reference"}, "activity_properties": {"url": {"value": "https://www.prnewswire.com/news-releases/rsv-and-hpiv-3-infections-drug-development-2018-pipeline-review-300645470.html"}, "title": "RSV and HPIV-3 Infections Drug Development: 2018 Pipeline Review", "author": "Research and Markets", "publisher": "PRNewswire"}, "activity_date": "2018-05-09", "entity_def_id": "press_reference", "activity_entities": [{"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}]}}, {"uuid": "45cd6cac-3883-475c-8925-e5847594d2ad", "properties": {"identifier": {"uuid": "45cd6cac-3883-475c-8925-e5847594d2ad", "value": "Post-IPO Equity - Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences-post-ipo-equity--45cd6cac", "entity_def_id": "funding_round"}, "activity_properties": {"money_raised": {"value": 581033, "currency": "USD", "value_usd": 581033}, "investment_type": "post_ipo_equity"}, "activity_date": "2017-12-19", "entity_def_id": "funding_round", "activity_entities": [{"role": "investee", "uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}]}}, {"uuid": "5e70f53f-c31d-045b-d520-d4e53204a841", "properties": {"identifier": {"uuid": "5e70f53f-c31d-045b-d520-d4e53204a841", "value": "Debt Financing - Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences-debt-financing--5e70f53f", "entity_def_id": "funding_round"}, "activity_properties": {"money_raised": {"value": 600000, "currency": "USD", "value_usd": 600000}, "investment_type": "debt_financing"}, "activity_date": "2016-04-07", "entity_def_id": "funding_round", "activity_entities": [{"role": "investee", "uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}]}}, {"uuid": "bdf8a881-8f75-b4b1-1608-56313407d880", "properties": {"identifier": {"uuid": "bdf8a881-8f75-b4b1-1608-56313407d880", "value": "Post-IPO Equity - Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences-post-ipo-equity--bdf8a881", "entity_def_id": "funding_round"}, "activity_properties": {"investment_type": "post_ipo_equity"}, "activity_date": "2008-06-03", "entity_def_id": "funding_round", "activity_entities": [{"role": "investee", "uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}]}}, {"uuid": "baef2585-faeb-a323-8d48-b69cf94010d3", "properties": {"identifier": {"uuid": "baef2585-faeb-a323-8d48-b69cf94010d3", "value": "AMARQ", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences-ipo--baef2585", "entity_def_id": "ipo"}, "activity_properties": {"stock_symbol": "AMARQ", "stock_exchange_symbol": "otcbb"}, "activity_date": "2003-01-10", "entity_def_id": "ipo", "activity_entities": [{"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}]}}, {"uuid": "e540d14c-8ce5-4f4e-c5f1-43b3a6ce3c80", "properties": {"identifier": {"uuid": "e540d14c-8ce5-4f4e-c5f1-43b3a6ce3c80", "value": "AMAR", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences-ipo--e540d14c", "entity_def_id": "ipo"}, "activity_properties": {"stock_symbol": "AMAR", "stock_exchange_symbol": "nasdaq"}, "activity_date": "1996-01-01", "entity_def_id": "ipo", "activity_entities": [{"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}]}}]}, "company_financials_highlights": {"funding_total": {"value": 21181033, "currency": "USD", "value_usd": 21181033}, "num_funding_rounds": 4}, "overview_company_fields": {"company_type": "for_profit", "stock_link": {"label": "OTCBB:AMARQ", "value": "https://www.google.com/finance?q=OTCBB:AMARQ"}}, "acquisitions_headline": {}, "builtwith_summary": {"builtwith_num_technologies_used": 14, "identifier": {"uuid": "8bf63d39-14a3-1847-ebab-8c8518bf801c", "value": "Amarillo Biosciences", "image_id": "ufx6zgykomwdrvw9zvo5", "permalink": "amarillo-biosciences", "entity_def_id": "organization"}}, "advisors_headline": {}, "about_short_description": {"short_description": "Amarillo Biosciences is a specialty biopharmaceutical company developing a patented formulation of interferon-alpha."}, "contacts_summary": {"lookup": [{"name": "Stephen Chen", "identifier": {"uuid": "17c3c0b8-a7ef-4cdf-b13d-3a191c098935", "value": "Stephen Chen", "entity_def_id": "contact"}, "linkedin": "stephen-chen-337210b1", "job_levels": ["l_100_individual", "l_500_exec"], "job_titles": [{"uuid": "55161575-f3e0-3dfb-a114-5c5d63d67d29", "value": "CEO", "permalink": "ceo", "entity_def_id": "job_title"}, {"uuid": "0e678094-b97c-381f-a87e-592f664994ce", "value": "Chairman", "permalink": "chairman", "entity_def_id": "job_title"}], "job_departments": ["management"], "num_phones": 1, "num_emails": 3}], "properties": {"num_contact_emails": 11, "num_contact_phones": 3, "num_contacts": 6}, "data": [{"name": "Stephen Chen", "identifier": {"uuid": "17c3c0b8-a7ef-4cdf-b13d-3a191c098935", "value": "Stephen Chen", "entity_def_id": "contact"}, "linkedin": "stephen-chen-337210b1", "job_levels": ["l_100_individual", "l_500_exec"], "job_titles": [{"uuid": "55161575-f3e0-3dfb-a114-5c5d63d67d29", "value": "CEO", "permalink": "ceo", "entity_def_id": "job_title"}, {"uuid": "0e678094-b97c-381f-a87e-592f664994ce", "value": "Chairman", "permalink": "chairman", "entity_def_id": "job_title"}], "job_departments": ["management"], "num_phones": 1, "num_emails": 3}]}, "event_appearances_headline": {}, "product": [], "apptopia_app_headline": {}, "company_overview_highlights": {"funding_total": {"value": 21181033, "currency": "USD", "value_usd": 21181033}, "num_contacts": 6, "num_current_positions": 2, "num_org_similarities": 4}}}}